• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Mass. gift ban repeal dies on the vine

Mass. gift ban repeal dies on the vine

August 4, 2010 By MassDevice staff

Gift ban

It looks like the Massachusetts "gift ban" won’t be repealed after all.

A provision to spike the Commonwealth’s ban on gifts for physicians from medical device and pharmaceutical companies failed to make it into the final omnibus economic development bill on Beacon Hill, meaning the gift ban remains intact unless the legislature brings up the issue again next session.

The Mass. House of Representatives voted to kill the 2008 gift ban law in early July.

The ban, passed in 2008 and put into effect last July, is aimed at reducing the influence of Big Pharma and device makers over healthcare. It requires companies to report any cash gift of more than $50 to a public database and mandates outright bans on gifts like promotional pens, tickets and other boondoggles. Meals are permitted in a hospital setting, but not at restaurants. Some exemptions include research-related payments.

Industry advocates say the ban creates red tape and increased expenses for medical device makers and pharma companies while squelching innovation. Some doctors complained that the ban also restricts their opportunity to receive training on the use of new devices.

Certain Massachusetts politicians and industry heads argued for the repeal based on purported negative economic effects. The critics said the ban was discouraging out-of-state interests from doing business in Massachusetts and said the ban had not led to demonstrable reductions in health care costs. The Mass. Senate debated on whether to lift the ban on taking doctors to restaurants.

Georgia Maheras, Private Market Policy Manager of Health Care for All, which authored the bill, said that the vote "reaffirmed [th legislature’s] commitment to keeping drug costs low." HCFA believes that pharmaceutical marketing corrupts the professional relationship between a patient and their prescriber.

Boston University law professor and pharmaceutical industry monitor Kevin Outterson told MassDevice in July that the law had not been in effect long enough to have an impact on the industry. The repeal’s inclusion in the economic development package is the result of a mixture of business and politics, Outterson said.

Filed Under: Business/Financial News, News Well Tagged With: Gift Bans

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy